Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Dual specificity protein kinase TTK | ||
Ligand | BDBM50533130 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1924421 (CHEMBL4427377) | ||
IC50 | 2.4±n/a nM | ||
Citation | Liu, Y; Laufer, R; Patel, NK; Ng, G; Sampson, PB; Li, SW; Lang, Y; Feher, M; Brokx, R; Beletskaya, I; Hodgson, R; Plotnikova, O; Awrey, DE; Qiu, W; Chirgadze, NY; Mason, JM; Wei, X; Lin, DC; Che, Y; Kiarash, R; Fletcher, GC; Mak, TW; Bray, MR; Pauls, HW Discovery of Pyrazolo[1,5-a]pyrimidine TTK Inhibitors: CFI-402257 is a Potent, Selective, Bioavailable Anticancer Agent. ACS Med Chem Lett7:671-5 (2016) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Dual specificity protein kinase TTK | |||
Name: | Dual specificity protein kinase TTK | ||
Synonyms: | Dual specificity protein kinase (TTK) | Dual specificity protein kinase TTK (MPS1) | MPS1 | MPS1L1 | Monopolar Spindle 1 (MPS1) | Monopolar Spindle 1 (Mps-1) | Monopolar Spindle 1 Kinase (MPS1) | Phosphotyrosine picked threonine-protein kinase (MPS1) | TTK | TTK_HUMAN | ||
Type: | Protein | ||
Mol. Mass.: | 97086.79 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P33981 | ||
Residue: | 857 | ||
Sequence: |
| ||
BDBM50533130 | |||
n/a | |||
Name | BDBM50533130 | ||
Synonyms: | CHEMBL4443683 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H34N6O2 | ||
Mol. Mass. | 474.5979 | ||
SMILES | Cc1cc(ccc1C(=O)NC1CC1)-c1cnn2c(NC[C@H]3C[C@H](O)C3)cc(NC3CCCC3)nc12 |r,wU:20.21,wD:22.24,(27.45,-12.4,;28.52,-11.29,;28.09,-9.81,;29.16,-8.7,;30.65,-9.06,;31.09,-10.54,;30.02,-11.66,;30.45,-13.14,;29.38,-14.25,;31.95,-13.5,;33.01,-12.39,;34.49,-11.95,;33.37,-10.89,;28.73,-7.23,;29.68,-6.01,;28.81,-4.74,;27.33,-5.17,;26.03,-4.37,;26.08,-2.83,;24.77,-2.02,;23.41,-2.74,;22.97,-4.23,;21.5,-3.78,;20.14,-4.51,;21.94,-2.31,;24.68,-5.09,;24.63,-6.63,;23.28,-7.37,;23.24,-8.91,;21.97,-9.77,;22.4,-11.25,;23.94,-11.29,;24.46,-9.84,;25.94,-7.43,;27.28,-6.71,)| | ||
Structure |